WebEzetimibe is a medication used to treat high blood cholesterol and certain other lipid abnormalities. [1] [2] Generally it is used together with dietary changes and a statin. [3] Alone, it is less preferred than a statin. [2] It is taken by mouth. [2] Web2 apr. 2003 · Ezetimibe is a recently approved inhibitor of intestinal cholesterol absorption that can be used in combination with statins without increasing the risk of myopathy. Ezetimibe produces an average additional 14% reduction in LDL-C when combined with simvastatin in various doses. 99
PCSK9 inhibitor, ezetimibe, and bempedoic acid: Evidence-based ...
Web16 nov. 2024 · Assessment Status: Assessment process complete: HTA ID: 20026b: Drug: Bempedoic acid/Ezetimibe: Brand: Nustendi® Indication: In adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet (a) in combination with a statin in patients unable to reach LDL-C … Web18 jun. 2024 · REAL-CAD did not have the greatest difference in LDL cholesterol levels (15 mg/dL versus 16–62 mg/dL in the trials in whites). ... Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015; 372:2387–2397. doi: 10.1056/NEJMoa1410489. quiz boj
Alternatives to Statins for Lowering Cholesterol
Web12 apr. 2024 · Primary endpoint rates did not differ between the combo group (moderate-intensity statin plus ezetimibe) or the monotherapy group (high-intensity statin monotherapy group). For patients aged ≥75 years, the primary outcome rates were 10.6% for the combination group and 12.3% for the monotherapy group (hazard ratio [HR], 0.87; … Web15 aug. 2024 · Overall, the two-statin combination yielded lower rates in the primary end points—0.9% and 0.8% for patients younger than 65 years and those 65 to 74 years of age, respectively, than the simvastatin monotherapy. In the 75-plus cohort, the combination therapy yielded the greatest absolute risk reduction (8.7%) in the primary end points or ... WebResults indicate that add-on ezetimibe is significantly more effective in reducing LDL-C levels than doubling statin dose, enabling more patients to achieve LDL-C goal. Meta … quiz boku no hero aluna nova 4